• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AIM
Click for more information
1.85% 79.5¢

AI-MEDIA TECHNOLOGIES LIMITED - News & Media

Market Cap $164.9M  ! watchlist Created with Sketch. Add to my watchlist
Industrials

Founded in Australia in 2003, technology company Ai-Media (ASX:AIM) has become a global... Founded in Australia in 2003, technology company Ai-Media (ASX:AIM) has become a global leader in the provision of high-quality live and recorded captioning, transcription and translation services. Its technology platform combines artificial intelligence and human expertise to deliver speech-to-text accuracy in three price points: automated (Lexi), semi-automated (Smart Lexi), and premium (Ai-Live).More

No News & Media currently available.

(20min delay)
Last
79.5¢ 		Change
-0.015(1.85%) 		Mkt cap ! $164.9M
Open High Low Value Volume
81.0¢ 81.0¢ 76.0¢ $313.4K 399.1K

Buyers (Bids)

No. Vol. Price($)
8 30595 79.0¢
 

Sellers (Offers)

Price($) Vol. No.
80.5¢ 1545 1
View Market Depth
Last trade - 14.00pm 02/10/2024 (20 minute delay) ?
Last
79.0¢ 		  Change
-0.015 ( 0.64 %)
Open High Low Volume
79.0¢ 81.0¢ 77.0¢ 116662
Last updated 14.06pm 02/10/2024 ?
AIM (ASX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
SPC to merge with Original Juice Co and Nature One Dairy The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.